AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Recall Of VAQTA Vaccines Issued.(Brief Article)
2001 DEC 26 - (NewsRx.com & NewsRx.net) -- Aventis Pasteur MSD is recalling the hepatitis A vaccines VAQTA Paediatric and VAQTA Adult launched originally in 1997 and 1998, respectively.
VAQTA products are being withdrawn only because it is possible that some syringes containing individual doses may not provide adequate protection against infection. They are not being withdrawn because of concerns over the vaccines' safety.
As a precaution to ensure adequate and continuing protection against infection with hepatitis A, reimmunization ...
- Sanofi Pasteur MSD's Gardasil beating GSK's Cervarix in race to dominate HPV...
- Newspaper article from: Pharma Marketletter October 30, 2006 700+ words
Sanofi Pasteur MSD is steaming ahead of GlaxoSmithKline...Gardasil, Richard Stubbins, Sanofi Pasteur MSD's managing director for the UK and...immunisations may be needed, said Sanofi Pasteur MSD UK medical director Nick Kitchin...
- Sweden adds Gardasil to reimbursement list.(Sanofi Pasteur MSD's product...
- Newspaper article from: Pharma Marketletter May 21, 2007 700+ words
European vaccines specialist Sanofi Pasteur MSD says that the Swedish Pharmaceutical Benefits Board has included...Marketletter March 5). Belgium also recommends Gardasil Sanofi Pasteur MSD also reported that Belgium's High Counsel of Health has...
- European Commission clears Sanofi MSD/Merck & Co's Zostavax in European...
- Newspaper article from: Pharma Marketletter June 5, 2006 700+ words
...was developed by US drug major Merck & Co and Sanofi Pasteur MSD, a joint venture that it set up with Sanofi Pasteur, the...Aventis, and will be marketed in Europe by the JV. Sanofi Pasteur MSD noted that the licences granted as part of the EC's decision...
- Sanofi Pasteur MSD's Gardasil becomes first HPV vaccine approved in...
- Newspaper article from: Pharma Marketletter October 2, 2006 700+ words
...of pre-cancerous vulvar and vaginal lesions, and 90% of genital warts in Europe. Didier Hoch, president of Sanofi Pasteur MSD, said that the fact that it has taken "just nine months for Gardasil to gain approval" is a "testament to the vaccine...
- Sanofi Pasteur MSD's Gardasil shows strong efficacy in FUTURE trials but...
- Newspaper article from: Pharma Marketletter May 21, 2007 700+ words
European vaccines specialist Sanofi Pasteur MSD says that strong efficacy data on its cervical cancer vaccine Gardasil (quadrivalent human papilloma virus [types 6, 11, 16...
- Sanofi Pasteur MSD submits ID flu vacc to EMEA.
- Newspaper article from: Pharma Marketletter February 18, 2008 700+ words
Sanofi Pasteur MSD, a joint venture between Sanofi-Aventis and Merck & Co, has applied for European approval of the first seasonal influenza...
- Sanofi Pasteur MSD submits new Gardasil cross-protection data to EMEA.(European...
- Newspaper article from: Pharma Marketletter April 30, 2007 700+ words
European vaccines specialist Sanofi Pasteur MSD has submitted cross-protection data to the European Medicines Agency (EMEA) to update the license for its human papillomavirus...
- Sanofi Pasteur MSD to submit MAA to EMEA for Gardasil.(Marketing Authorization...
- Newspaper article from: Pharma Marketletter December 19, 2005 700+ words
Sanofi Pasteur MSD, the vaccine unit of French drug major Sanofi Aventis, has submitted a Marketing Authorization Application for Gardasil (quadrivalent...
Source: HighBeam Research, Recall Of VAQTA Vaccines Issued.(Brief Article)